Novo Integrated Sciences, Inc. Announces Letter of Intent to Acquire U.S. Based Peripheral Neuropathy Health Care Companies

Stock Information for Novo Integrated Sciences Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Novo Integrated Sciences Inc.

Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results
Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement
Novo Integrated Sciences Provides Update on Certain Current Actions and Events
Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Agreement with Futura Surgicare Pvt Ltd.
Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note
Novo Integrated Sciences Appoints New President
Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results
Blacksheep Trust Files Partial Assignment of $1 Billion Dollar Gold Backed Bond to Novo Integrated Sciences

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.